Canada markets close in 5 hours 4 minutes

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (08HH.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
1.5280-0.0230 (-1.48%)
As of 08:05AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 6.85B
Enterprise Value 9.40B
Trailing P/E 16.16
Forward P/E 10.89
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.80
Price/Book (mrq)0.70
Enterprise Value/Revenue 1.81
Enterprise Value/EBITDA 17.14

Trading Information

Stock Price History

Beta (5Y Monthly) 0.62
52-Week Change 3-34.78%
S&P500 52-Week Change 325.51%
52 Week High 32.4020
52 Week Low 31.3390
50-Day Moving Average 31.5294
200-Day Moving Average 31.7420

Share Statistics

Avg Vol (3 month) 398
Avg Vol (10 day) 3N/A
Shares Outstanding 5551.94M
Implied Shares Outstanding 64.42B
Float 81.7B
% Held by Insiders 114.13%
% Held by Institutions 119.83%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.04
Forward Annual Dividend Yield 42.28%
Trailing Annual Dividend Rate 30.27
Trailing Annual Dividend Yield 317.41%
5 Year Average Dividend Yield 42.02
Payout Ratio 455.96%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 26, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 4.94%
Operating Margin (ttm)9.65%

Management Effectiveness

Return on Assets (ttm)0.61%
Return on Equity (ttm)4.56%

Income Statement

Revenue (ttm)40.69B
Revenue Per Share (ttm)15.26
Quarterly Revenue Growth (yoy)-6.60%
Gross Profit (ttm)N/A
EBITDA 3.87B
Net Income Avi to Common (ttm)2.01B
Diluted EPS (ttm)0.1000
Quarterly Earnings Growth (yoy)-38.20%

Balance Sheet

Total Cash (mrq)15.02B
Total Cash Per Share (mrq)5.62
Total Debt (mrq)34.9B
Total Debt/Equity (mrq)60.66%
Current Ratio (mrq)1.01
Book Value Per Share (mrq)17.34

Cash Flow Statement

Operating Cash Flow (ttm)3.46B
Levered Free Cash Flow (ttm)-2.51B